Mycoplasma genitalium has emerged as the causative agent of sexually transmitted syndromes including urethritis in men, cervicitis and pelvic inflammatory disease in women; however, testing should be limited to specific clinical scenarios. Treatment challenges include widespread macrolide resistance and the emergence of multidrug-resistant strains. Treatment failure is not uncommon and resistance-guided therapy currently offers the highest probability of cure.
|Number of pages||3|
|Publication status||Published - Mar 2020|